Concepedia

Author

Jennifer Desrosiers

Dana-Farber Brigham Cancer Center

Also Known As

J. Desrosiers, Jennifer Desrosiers

6

Publications

40

Citations

3

H-Index

14

Concepts

All Affiliations

Dana-Farber Brigham Cancer CenterHarvard UniversityDana-Farber Cancer Institute
JD

About

Jennifer Desrosiers is an author at Dana-Farber Brigham Cancer Center specializing in medicine, pharmacology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

1

1

25

2

Medicine

1

1

25

3

Immunology

1

1

25

4

Pharmacology

1

1

25

5

Cancer Therapeutics

1

1

25

Jennifer Desrosiers

×

2

Publications

35

Citations

2

H-Index

YearCitations

SACI-IO HR+: A randomized phase II trial of sacituzumab govitecan with or without pembrolizumab in patients with metastatic hormone receptor-positive/HER2-negative breast cancer.

Ana C. Garrido-Castro, Se Eun Kim, Jennifer Desrosiers,

Journal of Clinical Oncology

2024

25

Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancer

Ana C. Garrido-Castro, Noah Graham, Lestat R. Ali,

Journal for ImmunoTherapy of Cancer

2025

10

Page 1